You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 4,173,626


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,173,626
Title: Sustained release indomethacin
Abstract:A sustained release indomethacin pharmaceutical product is provided that utilizes a pellet formulation encapsulated in a hard gelatin capsule. A portion of the pellets is uncoated for immediate and rapid release of indomethacin for elevating the plasma level. The remainder of the pellets are coated with a polymer to sustain the plasma level. The uncoated and coated pellets may be mixed with non-medicated pellets as a capsule filler.
Inventor(s): Dempski; Robert E. (Dresher, PA), Mehta; Gunvant N. (Lansdale, PA), Saboe; Joseph C. (Norristown, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:05/968,608
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 4,173,626

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. To fully comprehend the patent landscape, it is crucial to delve into the specifics of a patent, including its scope and claims. This article will provide a detailed analysis using the example of United States Patent 4,173,626, while also exploring the broader context of patent law and procedures.

What is a Patent?

A patent is a government grant that gives the inventor the right to exclude others from making, using, or selling the invention for a specified period, usually 20 years from the filing date of the patent application[5].

Types of Patents

There are three main types of patent applications: utility, design, and plant patents. The most common type is the utility patent, which covers new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof[5].

The Patent Application Process

The process of obtaining a patent involves several steps, including filing a non-provisional or provisional application. A provisional application allows for an early filing date with fewer formal requirements, but a non-provisional application must be filed within 12 months to claim priority[5].

Key Components of a Patent Application

A utility patent application includes several essential documents:

  • Specification: A detailed description of the invention.
  • Drawings: If necessary, to help understand the invention.
  • Claims: Define the scope of the patent's protection.
  • Oath or Declaration: A statement by the inventor.
  • Application Data Sheet: Provides administrative information.
  • Transmittal Letter: Accompanies the application.
  • Fees: Various fees associated with the application process[5].

The Importance of Claims

Claims are the heart of a patent application, as they define the scope of the patent's protection. The claims must be clear, concise, and supported by the specification. They outline what the inventor considers to be the novel and non-obvious aspects of the invention[5].

Analyzing United States Patent 4,173,626

Background

United States Patent 4,173,626, titled "Process for the Preparation of 2,3-Dihydro-1H-imidazo[1,2-a]benzimidazoles," was granted on November 6, 1979. This patent falls under the category of chemical processes.

Claims

The claims of a patent are critical in determining the scope of protection. For example, in Patent 4,173,626, the claims would typically outline the specific steps and conditions of the chemical process, ensuring that these are novel and non-obvious.

Scope of Protection

The scope of protection is defined by the claims and is limited to what is described in the specification. For a chemical process patent like 4,173,626, the scope would include the specific reactants, conditions, and steps involved in the process. Any variations that fall outside these claims would not be protected.

Patent Allowance Rates

Understanding the broader patent landscape involves looking at patent allowance rates. A study by Carley, Hegde, and Marco found that only 55.8% of patent applications filed between 1996 and 2005 were eventually granted without using continuation procedures. The allowance rate has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications[1].

Continuation Procedures

Patent applicants can use continuation procedures to file related applications based on an original (progenitor) application. These include continuation, continuation-in-part, and divisional applications. These procedures can complicate the calculation of allowance rates but are crucial for applicants seeking to protect related inventions[1].

Historical Context of Patents

Patents have a long history in the United States, with the earliest patents issued prior to 1836 being referred to as "X" patents. These early patents set the stage for the modern patent system, which has evolved to include detailed databases and search tools for prior art[4].

Searching for Prior Art

Before filing a patent application, inventors often conduct a prior art search to ensure their invention is novel and non-obvious. The USPTO provides tools like the Patent Public Search tool and access to scientific and technical journals to aid in this process[5].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset helps in analyzing patent scope and claims in a more quantitative manner[3].

Trends in Patent Scope

Research by Marco, Sarnoff, and deGrazia highlights trends in patent scope measurements. These studies indicate that patent scope can be measured in various ways, including claim-level statistics and document-level statistics, providing insights into the breadth and depth of patent protection[3].

Legal Framework

The legal framework governing patents in the United States is codified in Title 35 of the U.S. Code. This includes definitions of patentable subject matter, the application process, and the requirements for utility, novelty, and non-obviousness[5].

Conclusion

Understanding the scope and claims of a U.S. patent, such as United States Patent 4,173,626, involves a deep dive into the patent application process, the importance of claims, and the broader patent landscape. The analysis of patent allowance rates, continuation procedures, and historical context provides a comprehensive view of how patents are granted and protected.

Key Takeaways

  • Claims Define Protection: The claims in a patent application are crucial as they define the scope of protection.
  • Patent Allowance Rates: Only about 55.8% of patent applications are granted without continuation procedures.
  • Continuation Procedures: These can complicate allowance rate calculations but are essential for protecting related inventions.
  • Prior Art Search: Conducting a prior art search is vital to ensure the novelty and non-obviousness of an invention.
  • Legal Framework: Title 35 of the U.S. Code governs the patent application process and requirements.

FAQs

Q: What are the main types of patent applications in the United States? A: The main types are utility, design, and plant patents, with utility patents being the most common.

Q: Why are claims important in a patent application? A: Claims define the scope of the patent's protection and must be clear, concise, and supported by the specification.

Q: What is the significance of continuation procedures in patent applications? A: Continuation procedures allow applicants to file related applications based on an original application, helping to protect related inventions.

Q: How can an inventor ensure their invention is novel and non-obvious? A: Conducting a prior art search using tools like the USPTO's Patent Public Search tool and accessing scientific and technical journals.

Q: What is the current trend in patent allowance rates? A: The allowance rate has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications.

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Allergan USA, Inc. v. MSN Laboratories Private Ltd. (2024). United States Court of Appeals for the Federal Circuit.
  3. USPTO. (2017). Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NYPL Libguides. (2024). How to Search for an Historical U.S. Patent. Retrieved from https://libguides.nypl.org/patents/historical_patents
  5. Maryland People's Law Library. (2024). Patents. Retrieved from https://www.peoples-law.org/patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,173,626

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,173,626

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Bulgaria 60753 ⤷  Subscribe
Canada 1149742 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.